 - Women of childbearing potential WOCBP must agree to follow instructions for methods of contraception for the duration of treatment with nivolumab plus 5 half-lives of nivolumab 19 weeks plus 30 days duration of ovulatory cycle for a total of 23 weeks post-treatment completion. 